{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:12:02Z","timestamp":1767870722721,"version":"3.49.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Carbapenem-resistant Enterobacteriaceae (CRE) pose a significant threat in urinary tract infections (UTIs), which are among the most common infectious diseases. This review summarizes the risk factors and treatment advances for CRE-associated UTIs. Key risk factors include advanced age, history of carbapenem use, invasive urological procedures, indwelling catheters, immunosuppression (e.g., in transplant recipients), and prolonged hospitalization. The prognosis of CRE UTIs is generally better than infections at other sites but is influenced by factors like ICU admission and treatment failure. Treatment relies heavily on novel antibiotics, such as ceftazidime-avibactam and the siderophore cephalosporin cefiderocol, often used in combination regimens to enhance efficacy and prevent resistance. Recent clinical trials have demonstrated the effectiveness and safety of cefiderocol against CRE UTIs. Research on adjuvants like metal ion chelators (e.g., copper, bismuth) to restore antibiotic susceptibility is promising. Future efforts should focus on developing new antimicrobials, establishing rapid diagnostics for precise control, and conducting large-scale studies to optimize individual treatment strategies and infection control measures to improve patient outcomes and curb CRE spread.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1724851","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:35:00Z","timestamp":1767854100000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors and treatment advances for carbapenem-resistant Enterobacteriaceae infections in the urinary tract"],"prefix":"10.3389","volume":"15","author":[{"given":"Xuming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyue","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/phar.2476","article-title":"Cefiderocol: A novel siderophore cephalosporin against multidrug-resistant gram-negative pathogens","volume":"40","author":"Abdul-Mutakabbir","year":"2020","journal-title":"Pharmacotherapy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/medicina60020214","article-title":"Carbapenem-resistant enterobacteriaceae in urinary tract infections: from biological insights to emerging therapeutic alternatives","volume":"60","author":"Bologna","year":"2024","journal-title":"Med. (Kaunas)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12010139","article-title":"Comparative analysis of microbial species and multidrug resistance patterns associated with lower urinary tract infections in preterm and full-term births","volume":"12","author":"Bratosin","year":"2024","journal-title":"Microorganisms"},{"key":"B5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1128\/AAC.04284-14","article-title":"Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation","volume":"59","author":"Brizendine","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","unstructured":"China Antimicrobial Surveillance Network 2024"},{"key":"B7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1186\/s12879-016-1979-z","article-title":"A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome","volume":"16","author":"de Maio Carrilho","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0157821","DOI":"10.1128\/spectrum.01578-21","article-title":"Bismuth drugs reverse tet(X)-conferred tigecycline resistance in gram-negative bacteria","volume":"10","author":"Deng","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1432-2277.2007.00500.x","article-title":"Early and late urological complications corrected surgically following renal transplantation","volume":"20","author":"Dinckan","year":"2007","journal-title":"Transpl Int."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02280-17","article-title":"Copper ions and coordination complexes as novel carbapenem adjuvants","volume":"62","author":"Djoko","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: an emergent form of bacterial life","volume":"14","author":"Flemming","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"B12","first-page":"332","article-title":"Frequency of multidrug-resistant organisms cultured from urine of children undergoing clean intermittent catheterization","volume":"6","author":"Forster","year":"2017","journal-title":"J. Pediatr. Infect. Dis. Soc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/23744235.2021.1887511","article-title":"Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection","volume":"53","author":"Freire","year":"2021","journal-title":"Infect. Dis. (Lond)."},{"key":"B14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jgar.2020.10.013","article-title":"Institutional protocol adherence in the incidence of recurrent urinary tract infection after kidney transplantation","volume":"23","author":"Freire","year":"2020","journal-title":"J. Glob Antimicrob. Resist."},{"key":"B15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.37201\/req\/s02.03.2022","article-title":"Antibacterial spectrum of cefiderocol","author":"Gij\u00f3n Cordero","year":"2022","journal-title":"Rev. Esp Quimioter."},{"key":"B16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.transproceed.2019.01.020","article-title":"Association of double-J stenting in renal transplant patients with urinary tract colonization and infections in a multidrug-resistant microbe endemic nosocomial environment","volume":"51","author":"Imvrios","year":"2019","journal-title":"Transplant. Proc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e36980","DOI":"10.1097\/MD.0000000000036980","article-title":"Uropathogenic distribution and antibiotic resistance patterns according to multidrug-resistant bacteria colonization status in patients with stroke","volume":"103","author":"Kim","year":"2024","journal-title":"Med. (Baltimore)."},{"key":"B18","first-page":"239","article-title":"Carbapenem-resistant Klebsiella pneumonia infection outbreak in a tertiary urology clinic: analysis of influencing factors with a controlled trial","volume":"50","author":"Kizilay","year":"2020","journal-title":"Turk J. Med. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s40261-020-00955-x","article-title":"Cefiderocol, a new siderophore cephalosporin for the treatment of complicated urinary tract infections caused by multidrug-resistant pathogens: preclinical and clinical pharmacokinetics, pharmacodynamics, efficacy and safety","volume":"40","author":"Lee","year":"2020","journal-title":"Clin. Drug Investig."},{"key":"B20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/1120009X.2019.1688490","article-title":"Retrospective evaluation of the patients with urinary tract infections due to carbapenemase producing Enterobacteriaceae","volume":"32","author":"\u00d6nal","year":"2020","journal-title":"J. Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1073\/pnas.1809285115","article-title":"Copper inhibits peptidoglycan LD-transpeptidases suppressing \u03b2-lactam resistance due to bypass of penicillin-binding proteins","volume":"115","author":"Peters","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1473-3099(18)30554-1","article-title":"Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial","volume":"18","author":"Portsmouth","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","article-title":"The rapid spread of carbapenem-resistant Enterobacteriaceae","volume":"29","author":"Potter","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"B24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/tid.12450","article-title":"Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients","volume":"17","author":"Pouch","year":"2015","journal-title":"Transpl Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1128\/AAC.02445-13","article-title":"Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria","volume":"58","author":"Qureshi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.transproceed.2016.05.005","article-title":"Urinary tract infections and surgical site infections due to carbapenem-resistant enterobacteriaceae in renal transplant","volume":"48","author":"Rodrigues Dos Santos","year":"2016","journal-title":"Transplant. Proc."},{"key":"B27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.6002\/ect.2017.0197","article-title":"Self-expandable covered metallic stent (UVENTA) to treat a ureteral stricture after renal transplant: A case report","volume":"18","author":"Sedigh","year":"2020","journal-title":"Exp. Clin. Transplant."},{"key":"B28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s15010-012-0380-0","article-title":"Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study","volume":"41","author":"Shilo","year":"2013","journal-title":"Infection"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e14529","DOI":"10.1111\/petr.14529","article-title":"Systematic use of magnetic double J stent in pediatric kidney transplantation: A single-center experience","volume":"27","author":"Spagnoletti","year":"2023","journal-title":"Pediatr. Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s40265-021-01580-4","article-title":"Cefiderocol: A review in serious gram-negative bacterial infections","volume":"81","author":"Syed","year":"2021","journal-title":"Drugs"},{"key":"B31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of america 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin. Infect. Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/QCO.0000000000000228","article-title":"Global epidemiology of urinary tract infections","volume":"29","author":"Tandogdu","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12757","article-title":"Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation","volume":"19","author":"Varotti","year":"2017","journal-title":"Transpl Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1089\/end.2015.0188","article-title":"Use of self-expanding metallic ureteral stents in the secondary treatment of ureteral stenosis following kidney transplantation","volume":"29","author":"Xu","year":"2015","journal-title":"J. Endourol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01882-17","article-title":"Epidemiology of carbapenem-resistant enterobacteriaceae infections: report from the China CRE network","volume":"62","author":"Zhang","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e054971","DOI":"10.1136\/bmjopen-2021-054971","article-title":"Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis","volume":"11","author":"Zhou","year":"2021","journal-title":"BMJ Open"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1724851\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:35:01Z","timestamp":1767854101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1724851\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":37,"alternative-id":["10.3389\/fcimb.2025.1724851"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1724851","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"article-number":"1724851"}}